INNT
TOTAL INVALIDATION PROCESSED BY THE IB
05/07/2026
Back to search
Official data from USPTO
ROSUMEGA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
05/08/2026
Trademark type
Word
Nice classes
5
Filing date
10/24/2017
Registration date
07/31/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/14/2025
Last transaction
05/08/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
KR
Examiner
IM, JEAN H
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Kuhnil Pharm. Co., Ltd.
Representatives
Mark J. Liss Leydig, Voit & Mayer, Ltd.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemico-pharmaceutical preparations for the treatment of dyslipidemia; preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of cardiovascular disease; drugs for medical purposesfor the treatment of dyslipidemia; cardiovascular pharmaceutical preparations; chemotherapeutics; hypoglycemic agents; anticoagulants; antibiotic preparations; antihypertensives; dermatological pharmaceutical products; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for tumor treatment; pharmaceutical agents affecting digestive organs; pharmaceutical preparations for activating cellular function; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; anti-inflammatory preparations; pharmaceutical preparations for urogenital organs; pharmaceutical preparations for immunity adjustment
Publications
History of USPTO decisions and trademark events.
28 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
04/15/2026
INPC
INVALIDATION PROCESSED
04/15/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/14/2025
C71T
CANCELLED SECTION 71
02/14/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/31/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/07/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/17/2018
FIMP
FINAL DISPOSITION PROCESSED
11/16/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/31/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
07/31/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/15/2018
PUBO
PUBLISHED FOR OPPOSITION
05/15/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/25/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/06/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/16/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/16/2018
ALIE
ASSIGNED TO LIE
03/14/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/02/2018
RFNP
REFUSAL PROCESSED BY IB
02/24/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/08/2018
RFRR
REFUSAL PROCESSED BY MPU
02/08/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/06/2018
CNRT
NON-FINAL ACTION WRITTEN
02/05/2018
DOCK
ASSIGNED TO EXAMINER
02/01/2018
MAFR
APPLICATION FILING RECEIPT MAILED
12/19/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/15/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/14/2017
Continuous trademark protection
Get notified about every new filing that threatens ROSUMEGA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.